Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Corvus Pharmaceuticals, Inc. | StockGist | StockGist

Companies
CRVS
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings CRVSSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Corvus Pharmaceuticals, Inc.

Filed Jan 30, 2026

Accepted Jan 29, 2026, 7:00 PM ET

CIK 0001626971

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Corvus Pharmaceuticals, Inc.

Person Type

IA

CUSIP: 221015100

Amendment History

3 filings

SCHEDULE 13G
Original
Viewing
Jan 30, 20260000102909-26-000049
SCHEDULE 13G/A
Amendment 1
Feb 13, 20260001104659-26-015263
SCHEDULE 13G/A
Amendment 2
Latest
Mar 26, 20260000102909-26-001004

Recent Filings

Corvus Pharmaceuticals, Inc.1 weeks ago

Corvus Pharmaceuticals, Inc.3 weeks ago

Corvus Pharmaceuticals, Inc.3 weeks ago

Corvus Pharmaceuticals, Inc.3 weeks ago

Corvus Pharmaceuticals, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice